Latest China Market News

Jindalee Lithium’s latest quarterly report confirms a 63-year life for its McDermitt Lithium Project, underpinned by robust financial metrics and a maiden ore reserve that taps just a fraction of its vast resource.

AdAlta Limited has bolstered its leadership team and progressed its 'East to West' cellular therapy strategy alongside its lead drug candidate AD-214, despite a tightening cash position. The company’s recent non-binding term sheet and new clinical data signal promising momentum in its biotech pipeline.

Fluence Corporation Limited delivered a standout Q4 2024 with $21.2 million revenue and $1 million EBITDA, driven by a strategic shift to higher-margin Smart Product Solutions. The company’s robust $88 million backlog and $50 million in new orders set the stage for ambitious growth in 2025.

Fluence Corporation delivered a standout Q4 2024 with revenue more than doubling prior quarters, overcoming project delays and market headwinds to set the stage for robust growth in 2025.

Australian Dairy Nutritionals Limited reports improved cash flow in Q2 FY25 and prepares for the strategic launch of its premium Future brand in China, aiming to reshape its growth trajectory.

Murray Cod Australia Ltd has secured a $43 million funding package from Westpac, advancing its Stanbridge site construction and expanding its biomass. The company also initiated exports to Thailand and is progressing towards entry into the Chinese market.